MasterSeal M 689 — new waterproofing solutions for the chemical and pharmaceutical industries
High elasticity and crack bridging ensure durability of the membrane even in contact with unstable substrates.
In chemical and pharmaceutical industries, environmentally hazardous chemicals and liquids are frequently an indispensable part of the production process. They require special measures for safe storage and handling. In addition, to prevent pollution of soil and water, secondary containment is required by national laws to control eventual liquid spillages to protect the environment. Especially for this purpose Master Builders Solutions by BASF offers waterproofing solutions also for complex industrial structures.
Secondary containment is theoretically only used when accidental spillage takes place but, in practice, minor quantities of chemicals often escape from valves, connections, joints, etc. These chemicals damage concrete structures and floors and can penetrate into soil causing, in some cases, severe contaminations. When waterproofing capabilities have to be complemented by resistance to chemicals solved in water, special resin based membranes are the best choice as they combine continuous, seamless and crack-bridging waterproofing properties with high chemical resistance.
MasterSeal M 689 combines this high chemical resistance to a wide range of chemicals with an outstanding elasticity and toughness ensuring long term durability of the membrane, even exposed to the most demanding situations. In addition, MasterSeal M 689 has high mechanical resistance, so it can even be used in storage areas with regular traffic. With high elastic and chemical resistance waterproofing membranes such as MasterSeal M 689, secondary containment facilities, basins, pipeline bridges or trafficked impounding basins, are long term protected and any leakage stopped before it reaches soil or groundwater.
MasterSeal M 689 shows high crack bridging capacities, both static (Class A5 according EN 1504 part 2) and dynamic (Class B4.2 according EN 1504 part 2) even at temperatures below zero. In addition, long-term chemical resistance to the exposure to a wide range of different agents even under pressure is proven and documented (Class III according EN 13529). That is why MasterSeal M 689 also fulfils the requirements of the German Wasser-Haushalts-Gesetz (WHG) for the use in so-called LAU (German: Lagern/ Abfüllen/ Umschlagen; English: Storage/ Filling/ Handling) areas in industrial environments.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance